Literature DB >> 31227281

Geographic, Temporal, and Sociodemographic Differences in Opioid Poisoning.

Elinor R Schoenfeld1, George S Leibowitz2, Yu Wang3, Xin Chen3, Wei Hou4, Sina Rashidian3, Mary M Saltz5, Joel H Saltz6, Fusheng Wang7.   

Abstract

INTRODUCTION: Not enough is known about the epidemiology of opioid poisoning to tailor interventions to help address the growing opioid crisis in the U.S. The objective of this study is to expand the current understanding of opioid poisoning through the use of data analytics to evaluate geographic, temporal, and sociodemographic differences of opioid poisoning- related hospital visits in a region of New York State with high opioid poisoning rates.
METHODS: This retrospective cohort study utilized patient-level New York State all-payer hospital data (2010-2016) combined with Census data to evaluate geographic, patient, and community factors for 9,714 Long Island residents with an opioid poisoning-related inpatient or outpatient hospital facility discharge. Temporal, 7-year opioid poisoning rates and trends were evaluated, and geographic maps were generated. Overall, significance tests and tests for linear trend were based upon logistic regression. Analyses were completed between 2017 and 2018.
RESULTS: Since 2010, Long Island and New York State opioid poisoning hospital visit rates have increased 2.5- to 2.7-fold (p<0.001). Opioid poisoning hospital visit rates decreased for men, white patients, and self-payers (p<0.001) and increased for Medicare payers (p<0.001). Communities with high opioid poisoning rates had lower median home values, higher percentages of high school graduates, were younger, and more often white patients (p<0.01). Maps displayed geographic patterns of communities with high opioid poisoning rates overall and by age group.
CONCLUSIONS: Findings highlight the changing demographics of the opioid poisoning epidemic and utility of data analytics tools to identify regions and patient populations to focus interventions. These population identification techniques can be applied in other communities and interventions.
Copyright © 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31227281     DOI: 10.1016/j.amepre.2019.03.020

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  5 in total

1.  A large-scale retrospective study of opioid poisoning in New York State with implications for targeted interventions.

Authors:  Xin Chen; Wei Hou; Sina Rashidian; Yu Wang; Xia Zhao; George Stuart Leibowitz; Richard N Rosenthal; Mary Saltz; Joel H Saltz; Elinor Randi Schoenfeld; Fusheng Wang
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 2.  Artificial intelligence in clinical and translational science: Successes, challenges and opportunities.

Authors:  Elmer V Bernstam; Paula K Shireman; Funda Meric-Bernstam; Meredith N Zozus; Xiaoqian Jiang; Bradley B Brimhall; Ashley K Windham; Susanne Schmidt; Shyam Visweswaran; Ye Ye; Heath Goodrum; Yaobin Ling; Seemran Barapatre; Michael J Becich
Journal:  Clin Transl Sci       Date:  2021-10-30       Impact factor: 4.689

3.  Differences in the attitudes towards the opioid crisis between metropolitan and rural counties in Central Texas: Secondary data analysis using cross-sectional data.

Authors:  Marcia G Ory; Shinduk Lee; Matthew Lee Smith; Joy P Alonzo; Heather R Clark; James N Burdine
Journal:  Prev Med Rep       Date:  2022-03-08

4.  Where Opioid Overdose Patients Live Far From Treatment: Geospatial Analysis of Underserved Populations in New York State.

Authors:  Kayley Abell-Hart; Sina Rashidian; Dejun Teng; Richard N Rosenthal; Fusheng Wang
Journal:  JMIR Public Health Surveill       Date:  2022-04-12

5.  Epidemiological and geospatial profile of the prescription opioid crisis in Ohio, United States.

Authors:  Andres Hernandez; Adam J Branscum; Jingjing Li; Neil J MacKinnon; Ana L Hincapie; Diego F Cuadros
Journal:  Sci Rep       Date:  2020-03-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.